Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-03 Sale | 2024-01-04 4:30 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $20 | $240,000 | 15,632 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-04 Option Award | 2024-04-08 5:20 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 44,607 | $0 | 77,549 (Direct) | View |
| 2024-04-08 Tax Withholding | 2024-04-08 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 791 | $17.9 | 77,549 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-08 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 2,694 | $0 | 77,549 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:25 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 514 | $19.7 | 22,118 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:25 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,750 | $0 | 22,118 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $8.83 | 15,632 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 4:30 pm | N/A 2029-09-16 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 12,000 | $0 | 15,632 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 7:06 pm | N/A 2033-08-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 49,050 | $0 | 76,486 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,338 | $17.76 | 76,486 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 4,556 | $0 | 76,486 (Direct) | View |
| 2023-04-26 Tax Withholding | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 291 | $11.15 | 14,395 (Direct) | View |
| 2023-04-26 Exercise | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 990 | $0 | 14,395 (Direct) | View |
| 2023-04-10 Tax Withholding | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 791 | $10.71 | 19,797 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 2,695 | $0 | 19,797 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 49,050 | $0 | 49,050 (Direct) | View |
| 2023-03-16 Tax Withholding | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 256 | $11.46 | 11,555 (Direct) | View |
| 2023-03-20 Tax Withholding | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 634 | $11.12 | 11,555 (Direct) | View |
| 2023-03-16 Exercise | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 3,030 | $0 | 11,555 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:10 pm | N/A 2032-08-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 75,437 | $0 | 88,691 (Direct) | View |
| 2022-09-02 Tax Withholding | 2022-09-06 4:10 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 547 | $11.44 | 88,691 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-06 4:10 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,861 | $0 | 88,691 (Direct) | View |
| 2022-04-26 Tax Withholding | 2022-04-28 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 282 | $9.99 | 9,328 (Direct) | View |
| 2022-04-26 Exercise | 2022-04-28 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 991 | $0 | 9,328 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:30 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 75,437 | $0 | 75,437 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,047 | $10.98 | 5,648 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 3,019 | $0 | 5,648 (Direct) | View |
| 2022-03-16 Tax Withholding | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer | 303 | $10.13 | 6,292 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer | 872 | $0 | 6,292 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:18 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Chief Financial Officer | 52,105 | $0 | 52,105 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-28 5:31 pm | N/A 2031-04-25 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 27,687 | $0 | 27,687 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 5,177 | $0 | 5,177 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:14 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO | 24,413 | $0 | 24,413 (Direct) | View |
| 2020-12-31 Exercise | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO | 4,404 | $0 | 3,107 (Direct) | View |
| 2020-12-31 Tax Withholding | 2021-01-05 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO | 1,297 | $17.67 | 3,107 (Direct) | View |
Ownership | 2020-12-23 5:03 pm | N/A 2028-05-22 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO | 0 | $0 | 108,703 (Direct) | View |